SNAP Form 4: Evan Spiegel 10b5-1 Sales and Charitable Gift Detailed
Rhea-AI Filing Summary
Snap Inc. director and CEO Evan Spiegel reported multiple transactions in Snap (SNAP) Class A common stock on August 13-14, 2025. The filings show sales under a Rule 10b5-1 trading plan of 1,375,255 shares on 08/13/2025 at a weighted average price of $7.2734 and 35,500 shares on 08/14/2025 at a weighted average price of $7.2451. Those sales reduced his direct beneficial ownership to 31,737,791 shares and then to 30,343,090 shares after a charitable gift reported as a separate 1,394,701-share disposition on 08/14/2025.
In addition, the filing discloses 3,027,844 Class A shares held indirectly in an irrevocable trust over which Mr. Spiegel acts as trustee with voting power but no financial interest. The filing notes the 10b5-1 plan was adopted on September 10, 2024 and modified on May 2, 2025 and provides share price ranges for the executed trades.
Positive
- Transactions executed under a documented Rule 10b5-1 plan, indicating pre-established trading instructions
- Charitable gift disclosed, showing a non-sale disposition of shares
- Full disclosure of indirect trust ownership with the trustee role and lack of financial interest clearly stated
Negative
- Large insider sales reported totaling 1,410,755 shares sold on 08/13-08/14/2025 which reduced direct beneficial ownership
- Substantial charitable gift of 1,394,701 shares decreased reported direct holdings
Insights
TL;DR: Insider sales under a 10b5-1 plan and a sizable charitable gift materially changed reported holdings but were executed via a pre-established plan.
The filing documents executed sales totaling 1,410,755 Class A shares across 08/13/2025 and 08/14/2025 at weighted average prices near $7.25 per share, plus a charitable gift of 1,394,701 shares. These transactions lowered Mr. Spiegel's reported direct beneficial ownership to 30,343,090 shares while disclosing 3,027,844 shares held indirectly in an irrevocable trust. The sales were effected pursuant to a Rule 10b5-1 plan established 09/10/2024 and modified 05/02/2025, which indicates pre-planned execution timing rather than ad hoc trading.
TL;DR: Use of a documented 10b5-1 plan and disclosure of trust arrangements demonstrate compliance-focused execution and transparency.
The Form 4 clearly discloses the relationship of the reporting person as Director, Chief Executive Officer and 10% owner, and it explains the nature of the indirect trust ownership and the charitable gift. The filing provides weighted average price ranges for the sales and states the 10b5-1 plan adoption and modification dates, which are important governance and compliance details for stakeholders assessing insider transaction intent and timing.